Thérapies Lasers Assistées par l'Image pour l'Oncologie (ONCO-THAI) - U1189
Administrative institutions
Université de Lille
CHU Lille
Inserm
Recent Submissions
-
Response assessment and outcome of combining immunotherapy and radiosurgery for brain metastasis from malignant melanoma
ESMO Open, 01-08-2020, 5Article dans une revue scientifique -
Evaluation of the relevance of surgery in patients with multiple myeloma harboring symptomatic spinal involvement: a retrospective case series
World Neurosurgery, 09-03-2018Article dans une revue scientifique -
Intracerebral efficacy and tolerance of nivolumab in non small-cell lung cancer patients with brain metastases
Lung cancer (Amsterdam, Netherlands), 01-02-2018, 116, 62-66Article dans une revue scientifique -
Microsurgical resection of fronto-temporo-insular gliomas in the non-dominant hemisphere, under general anesthesia using adjunct intraoperative mri and no cortical and subcortical mapping: a series of 20 consecutive patients
Scientific Reports, 26-03-2021, 11, 6994Article dans une revue scientifique -
Prognostic Impact of Surgical Margins for Hepatocellular Carcinoma According to Preoperative Alpha-Fetoprotein Level.
HPB : the official journal of the International Hepato Pancreato Biliary Association, 2022, 24; 6, 848--856Article dans une revue scientifique -
Active Ultrahigh‐Q (0.2×10^6) THz Topological Cavities on a Chip
Advanced Materials, Wiley-VCH Verlag, 14-05-2022, 2202370Article dans une revue scientifique -
FDG PET/CT allowing detection and follow-up of tumor cell transplantation
Annals of Nuclear Medicine, Springer Verlag, 01-04-2016, 30, 250-254Article dans une revue scientifique -
FDG PET/CT allowing detection and follow-up of tumor cell transplantation
Annals of Nuclear Medicine, 04-2016, 30, 250-254Article dans une revue scientifique -
Oral mucosal melanoma - a systematic review
Journal of stomatology, oral and maxillofacial surgery, 05-02-2022Article dans une revue scientifique -
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial
The Lancet, Elsevier, 01-2021, 397; 10272, 375-386Article dans une revue scientifiquefulltext